Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06512974 · ClinicalTrials.gov registry record · NA
NeuroTrainer Cognitive Training For Academic Focus
A NA study of ADHD - Combined Type and ADHD Predominantly Inattentive Type, sponsored by NeuroTrainer.
- Recruiting
- Registry status
- NA
- Development phase
- 155
- Enrollment target
- 3
- Study locations
NCT06512974: Recruiting NA study of ADHD - Combined Type and ADHD Predominantly Inattentive Type, sponsored by NeuroTrainer.
NCT06512974 is a NA study of ADHD - Combined Type and ADHD Predominantly Inattentive Type that is actively recruiting participants, run by NeuroTrainer. The registered enrollment target is 155 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06512974, a NA study of ADHD - Combined Type and ADHD Predominantly Inattentive Type, is actively recruiting participants, sponsored by NeuroTrainer.
- RECRUITING
- Registry status
- NA
- Development phase
- 155 participants
- Enrollment target
- 3
- Study locations
Study Summary
This clinical trial aims to evaluate the feasibility and efficacy of NeuroTrainer cognitive training in improving attentional and executive control functions in students with and without attention-related difficulties.
Primary Outcome
This test is designed to evaluate an individual's ability to concentrate their attention while inhibiting automatic response tendencies that could potentially hinder goal achievement. The assessment has demonstrated changes in ADHD cases (Buzy, et al., 2009) and may be sensitive to treatment effects (Epstein et al., 2011). The test will take approximately 3 minutes to complete. This is the reaction time (RT) outcome from this assessment.
Conditions Studied
Interventions
- BEHAVIORAL NeuroTrainer
Study Locations (3)
Michigan
- Marquette Senior High School - Marquette
Nebraska
- Westside High School - Omaha
Wisconsin
- One City Schools - Madison
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 155 participants |
| Start Date | 2024-09-01 |
| Est. Completion | 2026-02-28 |
| Phase | NA |
What NCT06512974 shows while recruiting
NCT06512974 is an interventional study that assigns participants to a tested intervention. The registered 155 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower).
The record links to 3 conditions, with ADHD - Combined Type appearing as the primary indexed condition, and to 1 intervention - of which NeuroTrainer is the first listed.
NCT06512974 reports a single indexed study location in Michigan, Nebraska, Wisconsin.
Frequently Asked Questions
What is clinical trial NCT06512974 about?
NCT06512974 is a clinical study titled "NeuroTrainer Cognitive Training For Academic Focus". This clinical trial aims to evaluate the feasibility and efficacy of NeuroTrainer cognitive training in improving attentional and executive control functions in students with and without attention-related difficulties.
What is the current status of trial NCT06512974?
This trial is currently recruiting. It is a NA study. The enrollment target is 155 participants. The study started on 2024-09-01. Estimated completion is 2026-02-28.
What conditions does trial NCT06512974 study?
This clinical trial studies the following conditions: ADHD - Combined Type, ADHD Predominantly Inattentive Type, ADHD, Predominantly Hyperactive - Impulsive.
What interventions are being tested in trial NCT06512974?
The interventions under investigation include: NeuroTrainer (BEHAVIORAL).
Who is sponsoring clinical trial NCT06512974?
This trial is sponsored by NeuroTrainer, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06512974 being conducted?
This trial has 3 study locations across Michigan, Nebraska, Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for ADHD - Combined Type
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06512974's enrollment target sits among peer trials
155 656th of 2000 higher than 1,345 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03223610 · 155 participants · Phase 1
Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid (ViPOR) in Relapsed/Refractory B-cell Lymphoma
- NCT05072483 · 155 participants
Natural History Study of CADASIL
- NCT05086497 · 155 participants · NA
WBSI Guided Personalized Delivery of TTFields
- NCT05412069 · 155 participants · NA
Trial to Evaluate Fecobionics in Fecal Incontinence (FI) (NORMAL and ABNORMAL-FI)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI